Literature DB >> 15986398

Cytologic diagnosis of Burkitt lymphoma.

Megan L Troxell1, Charles D Bangs, Athena M Cherry, Yasodha Natkunam, Christina S Kong.   

Abstract

BACKGROUND: The diagnosis and classification of lymphoma require correlation of morphologic, immunophenotypic, and molecular-cytogenetic studies. Fine-needle aspiration biopsy (FNAB) is a valuable diagnostic technique that allows material to be collected for these ancillary studies, and for morphologic evaluation.
METHODS: The authors report a series of seven cases clinically or morphologically suspicious for Burkitt lymphoma. Fluorescence in situ hybridization studies (FISH) for c-myc were performed on FNAB material and correlated with cytologic and immunophenotypic data.
RESULTS: Six of seven specimens were positive for c-myc rearrangement by FISH. However, only three of these cases represented Burkitt lymphoma, with one additional case of atypical Burkitt lymphoma. The other cases included diffuse large B-cell lymphoma, monomorphic posttransplant B-cell lymphoma, and an aggressive B-cell lymphoma, with the latter case negative for c-myc rearrangement by FISH. Of 2 non-Burkitt lymphoma specimens tested, 1 was positive for the immunoglobulin H/bcl-2 rearrangement, in addition to the c-myc rearrangement, suggesting transformation from a lower grade lymphoma.
CONCLUSIONS: These cases illustrated the value of FNAB in the diagnosis of Burkitt lymphoma, as well as the importance of obtaining material for, and integrating results of, ancillary studies for the final diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15986398     DOI: 10.1002/cncr.21307

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Primary Breast Burkitt's Lymphoma in an HIV-Infected Woman.

Authors:  Bangaly Traoré; Marie-Eve Fondrevelle; Mamoudou Condé; Catherine Chassagne-Clément; Tidiane Kourouma; Ahmed Monzomba Keita; Moussa Koulibaly; Bakary Sidiki Sylla
Journal:  Case Rep Med       Date:  2015-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.